Hypoglycemia-Sensing Neurons of the Ventromedial Hypothalamus Require AMPK-Induced Txn2 Expression but Are Dispensable for Physiological Counterregulation

Autor: Salima Metref, Marc Foretz, Simon Quenneville, Davide Basco, Benoit Viollet, Gwenaël Labouèbe, Bernard Thorens
Přispěvatelé: Institut Cochin, INSERM U1016, CNRS UMR8104, Université Paris Descartes, Paris, France
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Counterregulatory hormone
Blood Glucose
medicine.medical_specialty
Patch-Clamp Techniques
Endocrinology
Diabetes and Metabolism

Hypoglycemia
AMP-Activated Protein Kinases
03 medical and health sciences
0302 clinical medicine
Thioredoxins
Internal medicine
Internal Medicine
medicine
Humans
Protein kinase A
Cells
Cultured

030304 developmental biology
Neurons
0303 health sciences
TXN2
Chemistry
AMPK
[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry
Molecular Biology/Molecular biology

[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism
medicine.disease
[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry
Molecular Biology/Biomolecules [q-bio.BM]

medicine.anatomical_structure
Ventromedial nucleus of the hypothalamus
Endocrinology
Glucose
Metabolism
nervous system
Hypothalamus
Ventromedial Hypothalamic Nucleus
Neuron
030217 neurology & neurosurgery
Zdroj: Diabetes
Diabetes, American Diabetes Association, 2020, 69 (11), pp.2253-2266. ⟨10.2337/db20-0577⟩
Diabetes, vol. 69, no. 11, pp. 2253-2266
ISSN: 0012-1797
Popis: International audience; The ventromedial nucleus of the hypothalamus (VMN) is involved in the counterregulatory response to hypoglycemia. VMN neurons activated by hypoglycemia (glucose-inhibited [GI] neurons) have been assumed to play a critical although untested role in this response. Here, we show that expression of a dominant negative form of AMPK or inactivation of AMPK α1 and α2 subunit genes in Sf1 neurons of the VMN selectively suppressed GI neuron activity. We found that Txn2, encoding a mitochondrial redox enzyme, was strongly downregulated in the absence of AMPK activity and that reexpression of Txn2 in Sf1 neurons restored GI neuron activity. In cell lines, Txn2 was required to limit glucopenia-induced reactive oxygen species production. In physiological studies, absence of GI neuron activity after AMPK suppression in the VMN had no impact on the counterregulatory hormone response to hypoglycemia or on feeding. Thus, AMPK is required for GI neuron activity by controlling the expression of the antioxidant enzyme Txn2. However, the glucose-sensing capacity of VMN GI neurons is not required for the normal counterregulatory response to hypoglycemia. Instead, it may represent a fail-safe system in case of impaired hypoglycemia sensing by peripherally located glucose detection systems that are connected to the VMN.
Databáze: OpenAIRE